MA39141A1 - Anticorps anti-tau(ps422) humanisés et leurs méthodes d'utilisation - Google Patents

Anticorps anti-tau(ps422) humanisés et leurs méthodes d'utilisation

Info

Publication number
MA39141A1
MA39141A1 MA39141A MA39141A MA39141A1 MA 39141 A1 MA39141 A1 MA 39141A1 MA 39141 A MA39141 A MA 39141A MA 39141 A MA39141 A MA 39141A MA 39141 A1 MA39141 A1 MA 39141A1
Authority
MA
Morocco
Prior art keywords
methods
humanized anti
tau antibodies
tau
antibodies
Prior art date
Application number
MA39141A
Other languages
English (en)
Inventor
Hubert Kettenberger
Guy Georges
Michael Schraeml
Bernd Bohrmann
Joerg Benz
Ulrich Goepfert
Fiona Grueninger
Olaf Mundigl
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority claimed from PCT/EP2014/078234 external-priority patent/WO2015091656A1/fr
Publication of MA39141A1 publication Critical patent/MA39141A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711Alzheimer's disease; Amyloid plaque core protein
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/90Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne des anticorps anti-tau(ps422) humain humanisés et des méthodes d'utilisation de ceux-ci.
MA39141A 2013-12-20 2014-12-17 Anticorps anti-tau(ps422) humanisés et leurs méthodes d'utilisation MA39141A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13199123 2013-12-20
PCT/EP2014/078234 WO2015091656A1 (fr) 2013-12-20 2014-12-17 Anticorps anti-tau(ps422) humanisés et leurs méthodes d'utilisation

Publications (1)

Publication Number Publication Date
MA39141A1 true MA39141A1 (fr) 2017-06-30

Family

ID=49876465

Family Applications (1)

Application Number Title Priority Date Filing Date
MA39141A MA39141A1 (fr) 2013-12-20 2014-12-17 Anticorps anti-tau(ps422) humanisés et leurs méthodes d'utilisation

Country Status (2)

Country Link
AR (1) AR098855A1 (fr)
MA (1) MA39141A1 (fr)

Also Published As

Publication number Publication date
AR098855A1 (es) 2016-06-15

Similar Documents

Publication Publication Date Title
MA40938A (fr) Anticorps anti-cd79b et méthodes d'utilisation desdits anticorps
MA40682A (fr) Anticorps anti-ox40 et procédés d'utilisation correspondants
MY191169A (en) Anti-fcrh5 antibodies
MA43018B1 (fr) Anticorps anti-pd1 et procédés d'utilisation
MA40576B1 (fr) Anticorps et immunoconjugués anti-her2
MA53356B1 (fr) Formulations sous-cutanées d'anticorps anti-cd38 et leurs utilisations
MA39248B1 (fr) Anticorps anti-jagged1 et procédés d'utilisation correspondants
MA39095A1 (fr) Anticorps et immunoconjugués anti-cd33
MA37538A2 (fr) Anticorps et immunoconjugués anti-ly6e et procédés d'utilisation
UY34721A (es) Anticuerpos anti-hla-b*27 y usos de éstos.
PH12014502132A1 (en) Anti-lgr5 antibodies and immunoconjugates
MA35712B1 (fr) Anticorps anti-htra1 et leurs procédés d'utilisation
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
MA40671A1 (fr) Anticorps anti-c10orf54 et leurs utilisations
MA35898B1 (fr) Anticorps anti-lrp5 et leurs procédés d'utilisation
CR20160270A (es) ANTICUERPOS ANTI-TAU (pS422) HUMANIZADOS Y MÉTODOS DE UTILIZACIÓN
MX2015012326A (es) Anticuerpos anti-crth2 y su uso.
CR20150247A (es) Anticuerpos de antihemaglutinina y métodos de uso
MX2014014376A (es) Anticuerpos de anti-biotina y metodos de uso.
BR112018002382A8 (pt) Novos anticorpos anti-gvpi humano e usos dos mesmos
BR112018009004A2 (pt) conjugados anti-cd3-folato e seus usos
MX2014014381A (es) Anticuerpos de anti-teofilina y metodos de uso.
MA39126B1 (fr) Synthèse d'enantiomère de progestérone et d'intermédiaires de celui-ci
MA39411A (fr) Synthèse de l'énantiomère de la progestérone et ses intermédiaires
MA39355A1 (fr) Anticorps anti-ox40 et procédés d'utilisation correspondants